Detalhe da pesquisa
1.
Direct costs of antineoplastic and supportive treatment for progressive multiple myeloma in a tax-based health system.
Future Oncol
; 17(25): 3331-3341, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34156281